These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36504906)
1. Elevated bile acid metabolism and microbiome are associated with suppressed cell proliferation and better survival in breast cancer. Wu R; Yu I; Tokumaru Y; Asaoka M; Oshi M; Yan L; Okuda S; Ishikawa T; Takabe K Am J Cancer Res; 2022; 12(11):5271-5285. PubMed ID: 36504906 [TBL] [Abstract][Full Text] [Related]
2. Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer. Oshi M; Gandhi S; Yan L; Tokumaru Y; Wu R; Yamada A; Matsuyama R; Endo I; Takabe K Breast Cancer Res Treat; 2022 Jul; 194(2):231-241. PubMed ID: 35639264 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironment. Wu R; Sarkar J; Tokumaru Y; Takabe Y; Oshi M; Asaoka M; Yan L; Ishikawa T; Takabe K Am J Cancer Res; 2022; 12(2):504-520. PubMed ID: 35261783 [TBL] [Abstract][Full Text] [Related]
4. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival. Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098 [TBL] [Abstract][Full Text] [Related]
5. High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer. Oshi M; Tokumaru Y; Benesch MG; Sugito N; Wu R; Yan L; Yamada A; Chishima T; Ishikawa T; Endo I; Takabe K Am J Cancer Res; 2022; 12(10):4840-4852. PubMed ID: 36381329 [TBL] [Abstract][Full Text] [Related]
6. High Nelson ED; Benesch MG; Wu R; Ishikawa T; Takabe K Am J Cancer Res; 2024; 14(1):227-242. PubMed ID: 38323277 [TBL] [Abstract][Full Text] [Related]
7. High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer. Wu R; Patel A; Tokumaru Y; Asaoka M; Oshi M; Yan L; Ishikawa T; Takabe K Breast Cancer Res Treat; 2022 May; 193(1):49-63. PubMed ID: 35249172 [TBL] [Abstract][Full Text] [Related]
8. APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival. Wu R; Oshi M; Asaoka M; Huyser MR; Tokumaru Y; Yamada A; Yan L; Endo I; Ishikawa T; Takabe K Am J Cancer Res; 2022; 12(2):744-762. PubMed ID: 35261799 [TBL] [Abstract][Full Text] [Related]
9. Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival. Oshi M; Tokumaru Y; Angarita FA; Lee L; Yan L; Matsuyama R; Endo I; Takabe K Sci Rep; 2021 Jun; 11(1):12541. PubMed ID: 34131208 [TBL] [Abstract][Full Text] [Related]
10. Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC). Tokumaru Y; Oshi M; Murthy V; Tian W; Yan L; Angarita FA; Nagahashi M; Matsuhashi N; Futamura M; Yoshida K; Miyoshi Y; Takabe K Am J Cancer Res; 2021; 11(11):5743-5755. PubMed ID: 34873491 [TBL] [Abstract][Full Text] [Related]
11. High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer. Tokumaru Y; Katsuta E; Oshi M; Sporn JC; Yan L; Le L; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357442 [TBL] [Abstract][Full Text] [Related]
12. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer. Song C; Shang F; Tu W; Liu X BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015 [TBL] [Abstract][Full Text] [Related]
13. Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response. Asaoka M; Patnaik SK; Zhang F; Ishikawa T; Takabe K Breast Cancer Res Treat; 2020 Jun; 181(2):309-322. PubMed ID: 32285241 [TBL] [Abstract][Full Text] [Related]
14. Conflicting roles of Oshi M; Gandhi S; Tokumaru Y; Yan L; Yamada A; Matsuyama R; Ishikawa T; Endo I; Takabe K Am J Cancer Res; 2021; 11(10):5094-5110. PubMed ID: 34765314 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer. Zhang H; Yu X; Yang J; He G; Zhang X; Wu X; Shen L; Zhou Y; Cheng X; Liu X; Zhu Y Front Immunol; 2022; 13():933779. PubMed ID: 36090993 [TBL] [Abstract][Full Text] [Related]
16. Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer. Chen F; Yang J; Guo Y; Su D; Sheng Y; Wu Y Front Immunol; 2023; 14():1140995. PubMed ID: 36999009 [TBL] [Abstract][Full Text] [Related]
17. Liver- and Microbiome-derived Bile Acids Accumulate in Human Breast Tumors and Inhibit Growth and Improve Patient Survival. Tang W; Putluri V; Ambati CR; Dorsey TH; Putluri N; Ambs S Clin Cancer Res; 2019 Oct; 25(19):5972-5983. PubMed ID: 31296531 [TBL] [Abstract][Full Text] [Related]
18. High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer. Satyananda V; Oshi M; Endo I; Takabe K Ann Surg Oncol; 2021 Nov; 28(12):7356-7365. PubMed ID: 33966140 [TBL] [Abstract][Full Text] [Related]
19. Increased apoptosis is associated with robust immune cell infiltration and cytolytic activity in breast cancer. Murthy V; Oshi M; Tokumaru Y; Endo I; Takabe K Am J Cancer Res; 2021; 11(7):3674-3687. PubMed ID: 34354867 [TBL] [Abstract][Full Text] [Related]
20. Maternal obesogenic diet regulates offspring bile acid homeostasis and hepatic lipid metabolism via the gut microbiome in mice. Thompson MD; Kang J; Faerber A; Hinrichs H; Özler O; Cowen J; Xie Y; Tarr PI; Davidson NO Am J Physiol Gastrointest Liver Physiol; 2022 Mar; 322(3):G295-G309. PubMed ID: 34984925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]